Dementia is a chronic and progressive syndrome related to various brain illnesses that have a severe effect on critical brain functions such as thinking, memory as well as behavior and the adverse effect on the patient's ability to handle day to day activities.
Right now, research firms are coming up with the idea of funding studies on dementia to find a possible solution to the illness. These organizations are also dedicated to supporting other organizations with similar goals as far as dementia is concerned. There are currently no tangible results on dementia, but experts are hoping to find ways to diagnose dementia and prevent or treat it altogether.
There are current investigations going on to study problematic proteins and their response in people who suffer from dementia. Alzheimer or AD is thought to be triggered by the accumulation of certain proteins in the brain cells, and this leads to neurone dysfunction in people suffering from the condition. If researchers can find a way to prevent or stop the accumulation of this protein, it would be a great milestone towards controlling dementia.
Although Dementia disease is associated with the general impaired cognitive decline, some patients with this condition score high and do not show the general signs of low memory performance. However, researchers have determined that a big number of dementia patients always show correlated lopsidedness in the memory scores used for its study.
The observed differences between people who score low in cognitive tests and don't develop dementia poses future research questions. Dementia study is also complicated in a way because it largely depends on memory tests. Age, sex, race and education are also factors that can show differences in cognitive memory tests regardless of whether the patients have developed dementia or not.
Cognitive impairment might not worry patients. It might even not show signs of worsening conditions but can be a base for worsening dementia. Before you know it, mild memory impairment can lead to serious Alzheimer and serious dementia even if the patients did not show worrying memory tests during research studies or during clinical diagnosis.
Future research work is expected to take a more open form that allows integration of research endeavors with public service. This is expected to increase public participation in the core of dementia research as a bid to increase awareness on the diseases while underscoring the role that research plays in stepping up to the challenges of dementia.
Patients with mild dementia symptoms have shown remarkable improvements when drugs such as solanezumab were administered to them. But this is not in vain because it shows that with a little bit of more effort, the condition can be slowed down and treated in the end.
Finally, it is said that some Australian researchers found a possible natural remedy for dementia. They discovered a natural substance in the body cells known as "Spermidine" which they say can aid in memory loss, which is a major concern for patients suffering from dementia. The concentration of spermidine decreases as one gets older. Spermidine was administered to specimen of mammals such as rats and mice because they have similar memory functions to human beings. So they're hoping that the results will be transferred to humans someday in the near future.
Right now, research firms are coming up with the idea of funding studies on dementia to find a possible solution to the illness. These organizations are also dedicated to supporting other organizations with similar goals as far as dementia is concerned. There are currently no tangible results on dementia, but experts are hoping to find ways to diagnose dementia and prevent or treat it altogether.
There are current investigations going on to study problematic proteins and their response in people who suffer from dementia. Alzheimer or AD is thought to be triggered by the accumulation of certain proteins in the brain cells, and this leads to neurone dysfunction in people suffering from the condition. If researchers can find a way to prevent or stop the accumulation of this protein, it would be a great milestone towards controlling dementia.
Although Dementia disease is associated with the general impaired cognitive decline, some patients with this condition score high and do not show the general signs of low memory performance. However, researchers have determined that a big number of dementia patients always show correlated lopsidedness in the memory scores used for its study.
The observed differences between people who score low in cognitive tests and don't develop dementia poses future research questions. Dementia study is also complicated in a way because it largely depends on memory tests. Age, sex, race and education are also factors that can show differences in cognitive memory tests regardless of whether the patients have developed dementia or not.
Cognitive impairment might not worry patients. It might even not show signs of worsening conditions but can be a base for worsening dementia. Before you know it, mild memory impairment can lead to serious Alzheimer and serious dementia even if the patients did not show worrying memory tests during research studies or during clinical diagnosis.
Future research work is expected to take a more open form that allows integration of research endeavors with public service. This is expected to increase public participation in the core of dementia research as a bid to increase awareness on the diseases while underscoring the role that research plays in stepping up to the challenges of dementia.
Patients with mild dementia symptoms have shown remarkable improvements when drugs such as solanezumab were administered to them. But this is not in vain because it shows that with a little bit of more effort, the condition can be slowed down and treated in the end.
Finally, it is said that some Australian researchers found a possible natural remedy for dementia. They discovered a natural substance in the body cells known as "Spermidine" which they say can aid in memory loss, which is a major concern for patients suffering from dementia. The concentration of spermidine decreases as one gets older. Spermidine was administered to specimen of mammals such as rats and mice because they have similar memory functions to human beings. So they're hoping that the results will be transferred to humans someday in the near future.
About the Author:
There is a lot of information to learn when it comes to all the different stages in dementia. An excellent starting point for Research and the Future of Dementia information, would be to visit the following website at http://stagesofdementia.org.
No comments:
Post a Comment